Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARCBEST CORP /TX/ARCB · Entity 904 | Director | May 06, 2025 | May 08, 2025 |
| Gates Industrial Corp Ltd.GTES · Entity 3767 | Director | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARCBEST CORP /TX/
Report date May 06, 2025 · Filed May 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 18,375 |
Reported balance
After 2025-05-06 transaction · row 1
1 source rowRow 1 · 2025-05-06 · Grant · Acquired 2,725 · Balance 18,375 |
Gates Industrial Corp Ltd.
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 194,636 |
Reported balance
After 2026-03-04 transaction · row 1
1 source rowRow 1 · 2026-03-04 · Grant · Acquired 6,097 · Balance 194,636 F1: Represents time-based restricted stock units ("TBRSU") which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one share of the issuer ordinary shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents time-based restricted stock units ("TBRSU") which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one share of the issuer ordinary shares.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CSX CORP
Report date November 15, 2017 · Filed November 17, 2017
Section 16 reporting ended · disclosed 2017-11-17. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Change Healthcare Inc.
Report date October 03, 2022 · Filed October 05, 2022
Section 16 reporting ended · disclosed 2022-10-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-10-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2022-10-03 · Disposition to issuer · Disposed 215,238 · Balance 380,557 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Row 2 · 2022-10-03 · Disposition to issuer · Disposed 380,557 · Balance 0 F2: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs. Row 3 · 2022-10-03 · Grant · Acquired 119,309 · Balance 119,309 F3: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. Row 4 · 2022-10-03 · Disposition to issuer · Disposed 119,309 · Balance 0 F3: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2022-10-03 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2022-10-03 · Disposition to issuer · Disposed 140,000 · Balance 0 F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. F4: Reflects securities held by a trust, of which the Reporting Person and his spouse are trustees. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-10-03 · Disposition to issuer · Disposed 695,200 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F6: These options vest in three equal annual installments commencing on June 30, 2022. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.99 · Expires 2028-05-25 | Direct | 0 |
Reported balance
After 2022-10-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-10-03 · Disposition to issuer · Disposed 695,200 · Balance 0 F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7: These options are fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax.
F2: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs.
F3: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023.
F4: Reflects securities held by a trust, of which the Reporting Person and his spouse are trustees.
F5: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option.
F6: These options vest in three equal annual installments commencing on June 30, 2022.
F7: These options are fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 16:48 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | GrantOrdinary Shares | 6,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-015675 · wk-form4_1772833682.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,636 F1 · shares: Represents time-based restricted stock units ("TBRSU") which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one share of the issuer ordinary shares. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 18:30 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | Tax withholdingOrdinary Shares | 3 | $27.57 | $82.71 |
DisclosureSEC source: 0001628280-26-014197 · wk-form4_1772580602.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,539 F1 · shares: Represents ordinary shares withheld by the Company to satisfy payment of par value upon vesting of previously granted time-based restricted stock units (TBRSUs) in accordance with U.K. corporate law. Read SEC document |
| May 06, 2025 Filed May 8, 2025 20:21 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 2,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012351 · form4-05082025_080507.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,375 Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 19:01 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | PurchaseOrdinary Shares | 60,000 | $19.56 | $1,173,600.00 |
DisclosureSEC source: 0001062993-25-005180 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,452 F1 · price: The price reported in column 4 is the weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.365 to $19.81, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 19:03 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | Tax withholdingOrdinary Shares | 5 | $20.00 | $100.00 |
DisclosureSEC source: 0001062993-25-004783 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,452 F1 · shares: Represents ordinary shares withheld by the Company to satisfy payment of par value upon vesting of previously granted time-based restricted stock units (TBRSUs) in accordance with U.K. corporate law. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 17:40 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | GrantOrdinary Shares | 6,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004389 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,457 F1 · shares: Represents time-based restricted stock units ("TBRSU") which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one share of the issuer ordinary shares. Read SEC document |
| May 07, 2024 Filed May 9, 2024 14:36 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012663 · form4-05092024_020547.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,650 Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 18:20 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | GrantOrdinary Shares | 9,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005751 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,756 F1 · shares: Represents time-based restricted stock units ("TBRSU") which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one share of the issuer ordinary shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:00 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | Tax withholdingOrdinary Shares | 7 | $14.72 | $103.04 |
DisclosureSEC source: 0001062993-24-005556 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,005 F1 · shares: Represents ordinary shares withheld by the Company to satisfy payment of par value upon vesting of previously granted time-based restricted stock units (TBRSUs) in accordance with U.K. corporate law. Read SEC document |
| February 16, 2024 Filed Feb 20, 2024 16:56 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | PurchaseOrdinary Shares | 40,893 | $12.20 | $498,894.60 |
DisclosureSEC source: 0001062993-24-003703 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,012 Read SEC document |
| October 24, 2023 Filed Oct 26, 2023 17:29 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | Tax withholdingOrdinary Shares | 11 | $11.07 | $121.77 |
DisclosureSEC source: 0001062993-23-019723 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,119 F1 · shares: Represents ordinary shares withheld by the Company to satisfy payment of par value upon vesting of previously granted time-based restricted stock options (TBRSUs) in accordance with U.K. corporate law. Read SEC document |
| May 25, 2023 Filed May 26, 2023 16:51 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | PurchaseOrdinary Shares | 50,000 | $11.57 | $578,500.00 |
DisclosureSEC source: 0001062993-23-012347 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,130 Read SEC document |
| May 05, 2023 Filed May 9, 2023 20:28 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-028255 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,400 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 17:21 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | GrantOrdinary Shares | 9,567 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-005926 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,130 F1 · shares: Represents time-based restricted stock units ("TBRSU") which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one ordinary share of the registrant. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 16:43 UTC | Gates Industrial Corp Ltd. GTES · Entity 3767 | GrantOrdinary Shares | 11,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-021132 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,563 F1 · shares: Represents time-based restricted stock units (TBRSU) which, subject to the applicable award agreement, vest on the first anniversary date of the grant. Each TBRSU represents a contingent right to receive one ordinary share of the registrant. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerStock Option (right to buy) · Derivative | 695,200 | Not disclosed Strike: $18.99 | Not disclosed |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · derivative · entry 7 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 695,200 shares Expires 2028-05-25 F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F7 · derivative.exercise_date: These options are fully vested. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerStock Option (right to buy) · Derivative | 695,200 | Not disclosed Strike: $18.99 | Not disclosed |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · derivative · entry 6 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 695,200 shares Expires 2028-05-25 F5 · price: In connection with the Merger, stock option awards of the Issuer were automatically converted into an option to purchase a number of shares of common stock of UnitedHealth Group equal to the product of (i) the number of shares of Common Stock subject to the Issuer stock option multiplied by (ii) the Equity Award Exchange Ratio, at an exercise price per share equal to (i) the exercise price of the Issuer stock option divided by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group options will continue to be subject to the same terms and conditions as were applicable to the existing Issuer stock option. F6 · derivative.exercise_date: These options vest in three equal annual installments commencing on June 30, 2022. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 140,000 | $25.75 | $3,605,000.00 |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · nonDerivative · entry 5 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. F4 · ownership.nature: Reflects securities held by a trust, of which the Reporting Person and his spouse are trustees. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 119,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · nonDerivative · entry 4 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · shares: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. F3 · price: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 119,309 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · nonDerivative · entry 3 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,309 F3 · shares: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. F3 · price: Reflects performance based restricted stock units ("PSUs") granted on October 29, 2020 which were originally scheduled to vest based on the achievement of certain performance criteria. Pursuant to the Merger Agreement, PSUs of the Issuer were automatically converted into time-vesting UnitedHealth Group RSUs, with the number of shares of UnitedHealth Group common stock subject to the UnitedHealth Group RSUs equal to (i) the number of shares of Common Stock underlying the Issuer PSUs based on target performance multiplied by (ii) the Equity Award Exchange Ratio. Except as described herein, the UnitedHealth Group RSUs will continue to be subject to the same terms and conditions as were applicable to the Issuer PSUs, and will vest on June 17, 2023. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 380,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · nonDerivative · entry 2 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · shares: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs. F2 · price: Pursuant to the Merger Agreement, outstanding restricted stock units ("RSUs") of the Issuer were automatically converted into UnitedHealth Group RSUs calculated by taking the Merger Consideration and dividing it by the volume weighted average of the closing sale price per share of UnitedHealth Group common stock on each of the five full consecutive trading days ending on and including the third business day prior to the Merger closing date (the "Equity Award Exchange Ratio") and continue to be subject to the same terms and conditions (including vesting and settlement terms) as were applicable to the Issuer RSUs. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:31 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Disposition to issuerCommon Stock | 215,238 | $25.75 | $5,542,378.50 |
DisclosureSEC source: 0000899243-22-033010 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,557 F1 · price: On October 3, 2022, UnitedHealth Group Incorporated ("UnitedHealth Group") acquired Change Healthcare Inc. (the "Issuer") pursuant to that certain Agreement and Plan of Merger dated as of January 5, 2021 (the "Merger Agreement") by and among the Issuer, UnitedHealth Group and Cambridge Merger Sub Inc., a wholly owned subsidiary of UnitedHealth Group ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of UnitedHealth Group. At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Issuer (the "Common Stock") (other than certain excluded shares) automatically converted into the right to receive $25.75 per share in cash (the "Merger Consideration"), without interest and less any applicable holding tax. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 16:29 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 69,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020960 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 595,795 F1 · shares: Reflects an August 20, 2019 grant of performance based restricted stock units for which, on June 1, 2022, the Company certified performance. Such restricted stock units shall vest on July 2, 2022. Read SEC document |
| May 06, 2022 Filed May 10, 2022 21:17 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028096 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,000 Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 17:07 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantStock Option (Right to Buy) · Derivative | 695,200 | $0.00 Strike: $18.99 | $0.00 |
DisclosureSEC source: 0001062993-22-010729 · form4.xml · derivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 695,200 Underlying: Common Stock · 695,200 shares Expires 2028-05-25 F1 · derivative.exercise_date: Reflects a May 25, 2018 option grant which was previously not required to be reported as a derivative security. On April 21, 2022, the Company approved an additional service-based vesting opportunity for the options. Options to vest in three equal annual installments, subject to the Reporting Person's continued employment through the applicable vesting date, commencing upon the earlier to occur of: (a) the Exit Event or (b) June 30, 2022. Read SEC document |
| April 15, 2022 Filed Apr 19, 2022 17:03 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 190,159 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-010440 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,543 F1 · shares: Represents a grant of restricted stock units that vest in twelve equal quarterly installments commencing July 15, 2022. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 18:03 UTC | Change Healthcare Inc. CHNG · Entity 15437 | Tax withholdingCommon Stock | 36,274 | $21.44 | $777,714.56 |
DisclosureSEC source: 0001062993-21-013685 · form4.xml · nonDerivative · entry 2 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,625 F2 · shares: The shares reported were withheld from the shares deliverable upon vesting of the RSUs to satisfy tax withholding requirements. Read SEC document |
| December 28, 2021 Filed Dec 30, 2021 18:03 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 92,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-013685 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,899 F1 · shares: In connection with the anticipated transactions contemplated by the Agreement and Plan of Merger whereby the Issuer will be acquired by UnitedHealth Group Incorporated, the Compensation Committee of the Board of Directors of the Issuer accelerated the payment of certain restricted stock unit ("RSU") awards granted on (i) August 20, 2019, (ii) June 17, 2020, and (iii) April 1, 2021 in connection with certain tax-planning actions to mitigate adverse tax consequences of Section 280G and Section 4999 of the Internal Revenue Code of 1986 (as amended). Read SEC document |
| December 28, 2021 Filed Feb 25, 2022 16:42 UTC Amendment | Change Healthcare Inc. CHNG · Entity 15437 | Tax withholdingCommon Stock | 36,274 | $21.44 | $777,714.56 |
DisclosureSEC source: 0001062993-22-005770 · form4a.xml · nonDerivative · entry 4 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,384 F1 · kind: Represents a previously unreported withholding of shares in connection with previous vesting of RSUs. Reflects securities beneficially owned following the reported transaction as of the date of filing. F2 · balance_after: The Form 4 filed on December 30, 2021, is being amended to remove the transaction reporting the acquisition of certain underlying RSUs, as such shares had already previously been reported at the time of grant of the RSUs and to correct the amount of securities beneficially owned following the reported transaction. The amount of securities beneficially owned following the reported transaction reflects the current balance as of the filing date. Read SEC document |
| August 01, 2021 Filed Feb 25, 2022 16:42 UTC Amendment | Change Healthcare Inc. CHNG · Entity 15437 | Tax withholdingCommon Stock | 6,813 | $21.71 | $147,910.23 |
DisclosureSEC source: 0001062993-22-005770 · form4a.xml · nonDerivative · entry 3 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 372,658 F1 · kind: Represents a previously unreported withholding of shares in connection with previous vesting of RSUs. Reflects securities beneficially owned following the reported transaction as of the date of filing. Read SEC document |
| June 17, 2021 Filed Feb 25, 2022 16:42 UTC Amendment | Change Healthcare Inc. CHNG · Entity 15437 | Tax withholdingCommon Stock | 14,036 | $23.07 | $323,810.52 |
DisclosureSEC source: 0001062993-22-005770 · form4a.xml · nonDerivative · entry 2 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,471 F1 · kind: Represents a previously unreported withholding of shares in connection with previous vesting of RSUs. Reflects securities beneficially owned following the reported transaction as of the date of filing. Read SEC document |
| May 11, 2021 Filed May 13, 2021 23:36 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 1,300 | $87.87 | $114,231.00 |
DisclosureSEC source: 0001209191-21-032480 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,400 Read SEC document |
| April 01, 2021 Filed Apr 2, 2021 17:10 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 156,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-003404 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,719 F1 · shares: Represents a grant of restricted stock units that vest as follows: 25% will vest on each of April 1, 2022, 2023, 2024, and 2025. Read SEC document |
| August 20, 2020 Filed Feb 25, 2022 16:42 UTC Amendment | Change Healthcare Inc. CHNG · Entity 15437 | Tax withholdingCommon Stock | 5,212 | $12.93 | $67,391.16 |
DisclosureSEC source: 0001062993-22-005770 · form4a.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 393,507 F1 · kind: Represents a previously unreported withholding of shares in connection with previous vesting of RSUs. Reflects securities beneficially owned following the reported transaction as of the date of filing. Read SEC document |
| June 17, 2020 Filed Jun 19, 2020 16:46 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 142,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-002941 · form4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,921 F1 · shares: Represents a grant of restricted stock units that vest as follows: 25% will vest on each of June 17, 2021, 2022, 2023, and 2024. Read SEC document |
| June 10, 2020 Filed Jun 12, 2020 18:29 UTC | Change Healthcare Inc. CHNG · Entity 15437 | PurchaseCommon Stock | 100,000 | $12.00 | $1,200,000.00 |
DisclosureSEC source: 0000899243-20-016413 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 140,000 F1 · ownership.nature: Reflects securities held by a trust, of which the Reporting Person and his spouse are trustees. Read SEC document |
| May 12, 2020 Filed May 14, 2020 19:25 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 5,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-029122 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,100 Read SEC document |
| February 06, 2020 Filed Feb 19, 2020 21:52 UTC | ARCBEST CORP /TX/ ARCB · Entity 904 | GrantCommon Stock, par value $0.01 per share | 4,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010615 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| August 20, 2019 Filed Aug 22, 2019 17:27 UTC | Change Healthcare Inc. CHNG · Entity 15437 | GrantCommon Stock | 69,252 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-022322 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,252 F1 · shares: Represents a grant of restricted stock units that vest as follows: (a) 25% will vest on each of August 1, 2021, 2022 and 2023; and (b) 25% will vest on August 1, 2021, unless a Qualified MCK Exit (as defined in the LLC Agreement of Change Healthcare LLC) has occurred prior to the second anniversary of the Company's initial public offering, in which case such 25% of the restricted stock units will instead vest on the later of (x) August 20, 2020 and (y) the date that is 30 days after a Qualified MCK Exit. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 16:30 UTC | Change Healthcare Inc. CHNG · Entity 15437 | PurchaseCommon Stock | 40,000 | $13.73 | $549,200.00 |
DisclosureSEC source: 0000899243-19-022043 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 40,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $13.20 to $13.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. F2 · ownership.nature: Reflects securities held by a trust, of which the Reporting Person and his spouse are trustees. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 16:27 UTC | Change Healthcare Inc. CHNG · Entity 15437 | PurchaseCommon Stock | 30,000 | $13.00 | $390,000.00 |
DisclosureSEC source: 0000899243-19-019168 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 F1 · kind: Reflects shares of common stock of the Issuer purchased under the Issuer's Directed Share Program in connection with the Issuer's initial public offering. Read SEC document |
| May 05, 2017 Filed May 9, 2017 14:57 UTC Amendment | CSX CORP CSX · Entity 442 | Tax withholdingCommon Stock | 7,470 | $52.50 | $392,175.00 |
DisclosureSEC source: 0001209191-17-030789 · doc4a.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP - Chief Sales/Mktg Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,740 F1 · shares: Withholding of stock to satisfy tax obligation. Read SEC document |
| May 05, 2017 Filed May 9, 2017 14:24 UTC | CSX CORP CSX · Entity 442 | Tax withholdingCommon Stock | 7,470 | $52.50 | $392,175.00 |
DisclosureSEC source: 0001209191-17-030763 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · President - CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,740 F1 · shares: Withholding of stock to satisfy tax obligation. Read SEC document |
| February 22, 2017 Filed Mar 8, 2017 00:10 UTC | CSX CORP CSX · Entity 442 | GrantOption · Derivative | 74,140 | $48.39 Strike: $48.39 | $3,587,634.60 |
DisclosureSEC source: 0001209191-17-019029 · doc4.xml · derivative · entry 2 Eliasson Fredrik J · CIK 0001540752 · President - CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,140 Underlying: Common Stock · 74,140 shares Expires 2027-02-22 Read SEC document |
| February 22, 2017 Filed Mar 8, 2017 00:10 UTC | CSX CORP CSX · Entity 442 | GrantCommon Stock | 16,792 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-019029 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · President - CSMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,210 F1 · security: Restricted stock units awarded pursuant to the CSX Corporation 2017 - 2019 Long-Term Incentive Plan. The units vest on February 22, 2020. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 20:52 UTC | CSX CORP CSX · Entity 442 | Tax withholdingCommon Stock | 5,061 | $36.88 | $186,649.68 |
DisclosureSEC source: 0001209191-17-004808 · doc4.xml · nonDerivative · entry 2 Eliasson Fredrik J · CIK 0001540752 · EVP-Chief Sales/Mkting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,418 F2 · shares: Withholding of stock to satisfy tax obligation. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 20:52 UTC | CSX CORP CSX · Entity 442 | GrantCommon Stock | 18,162 | $36.88 | $669,814.56 |
DisclosureSEC source: 0001209191-17-004808 · doc4.xml · nonDerivative · entry 1 Eliasson Fredrik J · CIK 0001540752 · EVP-Chief Sales/Mkting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,479 F1 · shares: Shares awarded pursuant to the CSX 2014 - 2016 Long Term Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.